FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/01/2025
Voltar para busca
Dado oficial do USPTO
IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10
Data de depósito
13/09/2022
Data de registro
09/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/07/2024
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
IT
Examinador
BLAZICH, JOAN MICHELE
Unidade examinadora
N40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a circle containing a stylized trident with three partial circles above each tip, all above the stylized wording "IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY". A small shaded dot frames either side of "BIOTECHNOLOGY".
Titulares e representantes
Titulares
Immagina Biotechnology S.r.l.
Representantes
ALI R. LATIFI Tucker & Latifi, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical substances for analyses in laboratoriesother than for medical or veterinary purposeschemical for use in industry and natural elementsradiative elements for scientific purposes; nucleic acid sequencing programs other than for medical usenucleic acid sequences and chemical reagents for other than medical or veterinary purposes; chemical compositions and materials for use in sciencechemicals for use in science; chemical reagent mixtures in kit form comprised of chemical reagents other than for medical or veterinary use; chemical reagents other than for medical or veterinary purposes for use in the field of scientific research; chemicals for use in performing nucleic acid polymerase chain reactions other than medical and veterinary purposes; chemical diagnostic reagents for industrial purposescellular culture environmentscellular regulation agentsamino acidsdna fragmentsrna fragmentsdna probesrna probesmaterial for genetic cloningtagged antibodies for laboratory use; protein in raw material form for scientific and medical research; photosensitive chemicals being chemical preparations for use in photography; activators being chemicals for use in industry and science
Classe 5
Stem cells for medical purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for medical purposesfor treating cancer; chemical preparations for pharmaceutical purposes for the treatment of renal disease; diagnostic preparations for medical purposesfor diagnosing cardiovascular conditions; pharmaceutical preparations for treating cancer; clinical diagnostic reagents being diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; swabs for medical purposes; biological reagents for medical use; biotechnological preparations for medical use for treating cancer; antibodiescolostral antibodies for medical purposes; regulatory proteins for medical useprotein arrays for medical diagnosis purposes; enzymes for medical and veterinary purposes
Classe 10
Screening kitapparatus for DNA and RNA testing for medical purposes; biomedical diagnostic apparatusmolecular diagnostic devices for medical purposes used for nucleic acid testinginfectious disease testinggenetic testing; biomedical devices in the nature of cartridgesunfilledfor medical purposesfor loading biological samples for use in molecular diagnostic devices; testing sample collection equipmentswabs for obtaining biological samples from subjects for biomedical purposes; apparatus for dna and rna testing for medical purposes; apparatus for carrying-out diagnostic tests for medical purposesapparatus for DNA and RNA testing for medical purposes; screening kits for medical purposesapparatus for DNA and RNA testing for medical purposes; probes for medical purposes; sensor apparatus for medical use in diagnosispatient monitoring sensors and alarms
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/12/2024
FIMP
FINAL DISPOSITION PROCESSED
17/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/07/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
23/04/2024
PUBO
PUBLISHED FOR OPPOSITION
23/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/04/2024
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/03/2024
ALIE
ASSIGNED TO LIE
14/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/03/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
27/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2024
RFNT
REFUSAL PROCESSED BY IB
29/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/08/2023
RFRR
REFUSAL PROCESSED BY MPU
09/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/07/2023
CNRT
NON-FINAL ACTION WRITTEN
03/07/2023
DOCK
ASSIGNED TO EXAMINER
26/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/02/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
15/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.